Stay updated on CD40-L Blockade in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the CD40-L Blockade in GVHD Prevention Clinical Trial page.

Latest updates to the CD40-L Blockade in GVHD Prevention Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe new screenshot shows the same page layout and content as the previous screenshot, with no visible changes to core trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

- Check44 days agoChange DetectedThe page metadata has been updated to v3.1.0 with a current date and new study status, replacing the older revision v3.0.2 and 2025-06-05 date.SummaryDifference1%

- Check58 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' link was removed, with no other substantive content changes.SummaryDifference0.7%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%

- Check73 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple updates to study statuses and recruitment information. However, several location-related terms have been removed.SummaryDifference25%

Stay in the know with updates to CD40-L Blockade in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD40-L Blockade in GVHD Prevention Clinical Trial page.